Los Angeles, CA, United States of America

Nathaniel E David

This inventor holds 42 USPTO granted patents and 22 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Senescent Cell Therapy. Top assignees: Unity Biotechnology, Inc., Mayo Foundation for Medical Education and Research, Buck Institute for Research on Aging. Active years: 2008-2025.

USPTO Granted Patents = 42 (Patent Applications = 22)

% Patents Active = 85.7

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 3.8

ph-index = 11

Forward Citations = 242(Granted Patents)

Location History:

Calabasas, CA (US) (2018)
San Francisco, CA (US) (2008 - 2019)
Parsippany, NJ (US) (2019)
Los Angeles, CA (US) (2012 - 2021)
Madison, NJ (US) (2021)
Brisbane, CA (US) (2018 - 2024)
South San Francisco, CA (US) (2024)

Company Filing History:

25 out of 41

Unity Biotechnology, Inc.

patents

18 out of 1,802

Mayo Foundation for Medical Education and Research

patents

17 out of 51

Buck Institute for Research on Aging

patents

4. 14 out of 31

Kythera Biopharmaceuticals, Inc.

Johns Hopkins University

Buck Institute for Research Aging

patent

9. 1 out of 1,203

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Senescent Cells

Bcl-xL Inhibitors

Synthetic Bile Acids

Ophthalmic Conditions

Neurodegenerative Diseases

Pathological Angiogenesis

Cardiovascular Disease

Liver Disease

Atherosclerosis

Age-Related Disease

Pulmonary Conditions

Osteoarthritis

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12285427 - Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor (2025-04-29),

2. 11980616 - Treating liver disease by selectively eliminating senescent cells (2024-05-14),

3. 11963957 - Treating cardiovascular disease by selectively eliminating senescent cells (2024-04-23),

4. 11865123 - Methods of inhibiting pathological angiogenesis (2024-01-09),

5. 11351167 - Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue (2022-06-07),

6. 11202786 - Synthetic bile acid compositions and methods (2021-12-21),

7. 11129838 - Methods of inhibiting pathological angiogenesis (2021-09-28),

8. 11026955 - Synthetic bile acid compositions and methods (2021-06-08),

9. 10588916 - Technology to inhibit vascular changes that lead to vision loss in the eye (2020-03-17),

10. 10550378 - Composition comprising a gene vector that selectively depletes P16 positive senescent cells (2020-02-04),

11. 10517866 - Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor (2019-12-31),

12. 10478433 - Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss (2019-11-19),

13. 10478432 - Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye (2019-11-19),

14. 10434108 - Synthetic bile acid compositions and methods (2019-10-08),

15. 10434107 - Synthetic bile acid compositions and methods (2019-10-08),

Title: Inventor Nathaniel E David

Introduction: Nathaniel E David is a renowned inventor based in Los Angeles, CA. He is known for his groundbreaking innovations in various fields.

Latest Patents: Nathaniel E David holds several patents in the areas of biotechnology, healthcare, and pharmaceuticals, showcasing his continuous commitment to advancing these industries.

Career Highlights: With a successful career spanning over two decades, Nathaniel E David has founded multiple companies focused on developing cutting-edge technologies. He has been instrumental in bringing numerous products from concept to market, revolutionizing the way we approach healthcare and biotechnology.

Collaborations: Throughout his career, Nathaniel E David has collaborated with leading researchers, scientists, and industry experts to drive innovation and create impactful solutions to complex challenges. His collaborative efforts have led to the development of pioneering technologies that have the potential to transform the healthcare landscape.

Conclusion: Nathaniel E David's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the fields of biotechnology and healthcare continue to inspire the next generation of inventors and entrepreneurs.